Demcizumab Biosimilar – Anti-DLL4 mAb – Research Grade

Reference:
Size

,

Isotype

IgG2, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameDemcizumab Biosimilar - Anti-DLL4 mAb - Research Grade
SourceCAS 1243262-17-0
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsDemcizumab,OMP-21M18,DLL4 ,anti-DLL4
ReferencePX-TA1289
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody

Description of Demcizumab Biosimilar - Anti-DLL4 mAb - Research Grade

General information on Anti-DLL4 [Homo sapiens] (Demcizumab) Monoclonal Antibody

Demcizumab is investigated for the treatment of Nonsquamous Nonsmall Cell Neoplasm of Lung.

SDS-PAGE for Demcizumab Biosimilar - Anti-DLL4 mAb

Demcizumab Biosimilar - Anti-DLL4 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Demcizumab Biosimilar – Anti-DLL4 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human DLL4 recombinant protein
Antigen

Human DLL4 recombinant protein

PX-P5121 131$
Human IgG2 Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG2 Isotype Control antibody (HyHEL-10)

PTX17900 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products